Skip to content
Open access

Real-world validation of an AI-based non-mydriatic fundus camera in the diagnosis of diabetic retinopathy in Liberia

Sep 2026 · Frontiers in Digital Health · Vol 8 · 0 citations · 26 references
Medicine

TL;DR

The offline AI-based non-mydriatic fundus camera showed high sensitivity and specificity for detecting referable diabetic retinopathy among participants with at least one gradable eye in a general outpatient setting in Liberia, and its feasibility for AI-assisted detection of referable DR in resource-limited settings is supported.

Abstract

Introduction Diabetic retinopathy (DR) is a leading cause of preventable vision loss, yet access to retinal screening remains limited in low-resource settings such as Liberia. This study evaluated the real-world diagnostic performance of an offline artificial intelligence (AI)-enabled smartphone-based non-mydriatic fundus camera for detecting referable diabetic retinopathy in a routine general outpatient screening setting in Liberia. Methods This prospective study was conducted at the General Outpatient Department of John F. Kennedy Medical Center, Monrovia, Liberia. Adults aged 18 years and older were recruited through convenience sampling and underwent non-mydriatic fundus imaging using the Remidio Fundus on Phone (FOP-NM-10) integrated with an offline AI system. Fundus images were independently assessed by two trained optometrists using the International Clinical Diabetic Retinopathy (ICDR) classification, with disagreements adjudicated by a senior retinal ophthalmologist. Referable DR was defined as moderate non-proliferative DR, severe non-proliferative DR, or proliferative DR. Diagnostic performance was evaluated at the participant level among participants with at least one gradable eye. Results A total of 1,612 participants were enrolled, of whom 1,357 were included in the final analytical cohort. Of these, 1,198 (88.3%) had at least one gradable eye and were included in the diagnostic-performance analysis. Eleven participants were classified as having referable DR by the human reference standard. The AI system correctly classified 10 of these 11 participants, yielding a sensitivity of 90.9% (95% CI, 58.7%–100%). Among 1,187 participants without referable DR, 1,183 were correctly classified as negative, resulting in a specificity of 99.7% (95% CI, 99.1%–99.9%). The positive predictive value was 71.4% (95% CI, 41.9%–91.6%), and the negative predictive value was 99.9% (95% CI, 99.5%–99.9%). Conclusions In this prospective real-world study, the offline AI-based non-mydriatic fundus camera showed high sensitivity and specificity for detecting referable diabetic retinopathy among participants with at least one gradable eye in a general outpatient setting in Liberia. These findings support its feasibility for AI-assisted detection of referable DR in resource-limited settings.

Read PDF

Similar papers

Open access Sep 2026

Performance of AI-based diabetic retinopathy screening is highly dependent on evaluation setting: a five-year, multi-framework study

Despite near-perfect performance reported on benchmark datasets, the real-world behavior of artificial intelligence (AI) systems for diabetic retinopathy (DR) screening remains insufficiently characterized. Here, we report a multi-framework evaluation of OphtAI, a CE-marked AI system for automated detection of refera...

G. Quellec, M. Lamard, Sarah Matta et al. · 0 citations
Open access Sep 2026

Diabetic retinopathy screening using artificial intelligence: a comprehensive performance comparison on datasets from diverse populations and imaging modalities

The study highlights the impact of imaging equipment, demographics, and image quality on diagnostic performance and underscores the need for benchmarking AI-based DR screening tools using standardized datasets that encompass diverse populations and imaging conditions.

Philipp Schapotschnikow, Vladyslav Dusiak, Murat Osswald et al. · 0 citations
Review Aug 2026

Prevalence of Potentially Sight-Threatening Pathology Detected by Non-Mydriatic Fundus Photography in a National Diabetic Screening Platform.

BACKGROUND AND OBJECTIVE Hundreds, if not thousands, of non-mydriatic fundus images are acquired in primary care offices daily and uploaded for remote grading by ophthalmologists, retina specialists, and/or artificial intelligence. No prior studies of this magnitude have explored the yield of sight-threatening patholog...

F. Sarwar, Caitlin Kristoff, Shawn C. Kavoussi · 0 citations
Open access 2026

The use of a teachable machine in the detection of diabetic retinopathy from fundus examination databases and its application as a population screening method

INTRODUCTION: Diabetic retinopathy (DR) is one of the leading causes of preventable blindness, and early diagnosis is essential to reduce visual loss. Limited access to ophthalmologic screening in public health systems remains a significant barrier. Artificial intelligence (AI)–based analysis of fundus images has emerg...

Mariana Paes Leme Cardoso da Silva, V. L. Lima · 0 citations
Review Open access Aug 2026

Autonomous AI-driven point-of-care screening for diabetic retinopathy compared to reading center multi-expert clinical review: results from three prospective controlled pivotal validation studies with AEYE-DS in over 1,200 patients

Purpose Diabetic retinopathy (DR) remains the leading cause of blindness among working-age adults and requires regular screening to detect progression among the growing global diabetic population. This study evaluated the performance of AEYE-DS, an autonomous artificial intelligence (AI) system designed for high-throug...

Zack Dvey-Aharon, Moshe Livne, Danny Margalit et al. · 0 citations
Review Open access Aug 2026

Smartphone-Based Fundus Imaging in Global Eye Care: Closing the Gap.

Small-scale implementation and cost-effectiveness studies are needed to determine whether improved access to ophthalmic imaging can translate into sustainable and equitable eye-care services, and minimum reporting standards are suggested to increase comparability across studies.

R. Lechtenboehmer, C. Cleland, F. Malerbi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.